IRB Study Number 21-959
Status Recruiting
Phase Not Applicable
Location A Building - Crile Building
Institute Dermatology and Plastic Surgery Institute
Description
The purpose of this study is to better understand the immune response to basal cell carcinoma treated with PDT in order to develop new methods of treating basal cell carcinoma. Previous research suggests that PDT alters the immune response, possibly in a way that could promote better tumor clearance when combined with other treatments. Overall, your participation in this study will help us to better understand the anti-tumor immune response when basal cell carcinoma is treated with PDT.
Inclusion Criteria
Must be an adult patient (++>++ 18 yrs) who is scheduled to undergo surgical excision within the Dermatologic Surgery unit of the Department of Dermatology, Cleveland Clinic.
Must have at least one BCC tumor eligible for removal by surgical excision.
Men and women of any ethnic group are eligible for this trial.
Must provide informed consent to participate in the trial.
Exclusion Criteria
Pregnant or breastfeeding
Currently being treated for other cancers with medical or radiation therapy
Known hypersensitivity to 5-aminolevulinic acid
History of a photosensitivity disease, e.g., porphyria cutanea tarda
